Neurology and Neurosurgery - Global Neurology Academy

97-112 of 455

Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
NeuroFrontiers
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiers
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiers
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiers
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Treatment of a Broader Population of Patients With DMD
Treatment of a Broader Population of Patients With DMD
CME/CE
Treatment of a Broader Population of Patients With DMD
1.00 credit
- Crystal Proud, MD
- Erika Finanger, MD, MS
1.00 credit
MinuteCE®
Establishing Our Foundation of LGMD2I/R9
1.00 credit 8 episodes
- John Vissing, MD, DMSci
- Conrad Weihl, MD, PhD
1.00 credit 8 episodes
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
MinuteCE®
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
1.00 program credit
- Conrad Weihl, MD, PhD
1.00 program credit
Recognizing Early Signs of LGMD2I/R9 
Recognizing Early Signs of LGMD2I/R9 
MinuteCE®
Recognizing Early Signs of LGMD2I/R9 
1.00 program credit
- John Vissing, MD, DMSci
1.00 program credit
Navigating the LGMD2I/R9 Diagnostic Pathway
Navigating the LGMD2I/R9 Diagnostic Pathway
MinuteCE®
Navigating the LGMD2I/R9 Diagnostic Pathway
1.00 program credit
- Conrad Weihl, MD, PhD
1.00 program credit
The Role of Multidisciplinary Care in LGMD2I/R9  
The Role of Multidisciplinary Care in LGMD2I/R9  
MinuteCE®
The Role of Multidisciplinary Care in LGMD2I/R9  
1.00 program credit
- Conrad Weihl, MD, PhD
1.00 program credit
Advancing Care: Clinical Innovations on the Horizon 
Advancing Care: Clinical Innovations on the Horizon 
MinuteCE®
Advancing Care: Clinical Innovations on the Horizon 
1.00 program credit
- John Vissing, MD, DMSci
1.00 program credit
Optimizing Patient Management Strategies 
Optimizing Patient Management Strategies 
MinuteCE®
Optimizing Patient Management Strategies 
1.00 program credit
- John Vissing, MD, DMSci
1.00 program credit
Integrating Perspectives: The Value of Patient and Caregiver Input
Integrating Perspectives: The Value of Patient and Caregiver Input
MinuteCE®
Integrating Perspectives: The Value of Patient and Caregiver Input
1.00 program credit
- John Vissing, MD, DMSci
- Conrad Weihl, MD, PhD
1.00 program credit
Bridging Gaps in LGMD Care
Bridging Gaps in LGMD Care
MinuteCE®
Bridging Gaps in LGMD Care
1.00 program credit
- John Vissing, MD, DMSci
- Conrad Weihl, MD, PhD
1.00 program credit
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
On the Frontlines of Migraine
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
MinuteCE®
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
0.50 credits 5 episodes
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 credits 5 episodes

Previous
1
2
…
5
6
7
8
9
…
28
29
Next

7/11